JORDAN ROZENBLUM

• Exceeded territory targets by building strategic urology partnerships, increasing new patient starts, and expanding market share
• Revived Dallas market by implementing targeted strategies, generating new growth in previously stagnant territory
• Added 144 new intermittent catheter patients, driving sustained territory growth
• Ranked #3 nationally in straight catheter sales (103% to plan) and #5 nationwide in overall percent-to-goal
• Managed urology accounts across Texas (excluding Houston) and southern New Mexico, ensuring consistent account support and service delivery
• Strengthened clinician relationships by providing responsive service and streamlining ordering processes, enhancing customer satisfaction
• Drove brand growth for Hollister, achieving a 3:1 sales ratio vs. competitors

Surpassed annual written prescription goals, achieving 101.72% in 2023 and 101.3% in 2024, demonstrating consistent high performance

• Achieved 5% territory prescription growth in Q4 2024, contributing to market expansion
• Ranked in Top 3 district sales at Spring National Meeting for exceptional sales performance
• Launched new indication for co-promoted product from Eli Lilly and Company and Boehringer Ingelheim, enhancing product adoption and awareness.

• Closed sales across 200+ product lines, generating revenue for diverse business owners
• Created purchase orders aligned with seasonal trends and client demand to optimize inventory
• Managed inventory and vendors using MarketTime software to streamline order fulfillment